<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003623'>Neonatal-onset</z:hpo> multisystem <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e>) is due to mutations in the CIAS1 gene </plain></SENT>
<SENT sid="1" pm="."><plain>We describe the case of a 5-year-old boy with <z:hpo ids='HP_0003623'>neonatal onset</z:hpo> of <z:hpo ids='HP_0001025'>urticaria</z:hpo>-like <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001945'>fever</z:hpo>, laboratory findings of systemic <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:hpo ids='HP_0001433'>hepatosplenomegaly</z:hpo>, and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0006082'>CNS inflammation</z:mp> associated with <z:hpo ids='HP_0000407'>sensorineural deafness</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Sequence analysis of exon 3 of the CIAS1 gene revealed a novel C1754A/S331R mutation </plain></SENT>
<SENT sid="3" pm="."><plain>Since experimental evidence suggests that patients with cryopyrin-associated <z:e sem="disease" ids="C0585274" disease_type="Disease or Syndrome" abbrv="">periodic syndromes</z:e> (CAPS) could respond to inhibition of binding of interleukin IL-1alpha and IL-1beta to the IL-1 receptor type 1, we treated the child with the IL-1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> anakinra </plain></SENT>
<SENT sid="4" pm="."><plain>A remarkable clinical and serological response to therapy was observed, suggesting that pharmacological inhibition of the IL-1 signaling pathway offers an important new treatment option for patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e> </plain></SENT>
</text></document>